미국의 가이드와이어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 부문별 예측(2025-2033년)

U.S. Guidewires Market Summary

The U.S. guidewires market size was estimated at USD 830.6 million in 2024 and is projected to reach USD 1,274.3 million by 2033, growing at a CAGR of 4.87% from 2025 to 2033. The increasing prevalence of urological disorders, cardiovascular diseases, and Peripheral Artery Disease (PAD) is significantly driving the growth of the market.

Moreover, a growing number of minimally invasive surgeries, paired with a rising geriatric population, presents an opportunity for increased product demand. Factors such as a rising number of coronary & peripheral intervention procedures and an increase in the geriatric population are resulting in high demand for minimally invasive surgeries in the country. This is expected to have a positive impact on the market in the years to come. A majority of people in the U.S. are inclined towards noninvasive surgeries owing to the probability of high infection associated with invasive procedures. According to data published by Yale Medicine, approximately 900,000 percutaneous coronary interventions (PCIs) are performed in the U.S. every year. Thus, such a high procedural volume is anticipated to support the nationwide demand for guidewires.

Moreover, the rising number of clinical trials and research studies aimed at expanding the applications of guidewires is expected to significantly support the country's market growth. These trials are increasingly focused on assessing the safety and efficacy of guidewires across various procedures, as well as accelerating the development of novel and advanced products. Research institutions, academic centers, and industry players are actively collaborating on these investigations. Favorable clinical outcomes validate product performance, facilitating regulatory approvals, enhancing clinician adoption, and contributing to broader market expansion.

U.S. Guidewires Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. guidewires market report based on product:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Guidewires Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased Prevalence of Chronic Diseases
    • 3.2.1.2. Advancements in Medical Technology
    • 3.2.1.3. Increasing Preference for Minimally Invasive Procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Alternative Treatment Options
    • 3.2.2.2. Stringent Regulatory Requirements
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Supportive Government Initiatives
    • 3.2.3.2. Rising Clinical Studies and Trials
    • 3.2.3.3. Growing Expansion of Healthcare Infrastructure
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product Recalls
    • 3.2.4.2. Potential Risks And Complications
• 3.3. U.S. Guidewires Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Guidewires Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Guidewires Market Product Movement Analysis
• 4.3. U.S. Guidewires Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Coronary Guidewires
  • 4.4.1. Coronary Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Peripheral Guidewires
  • 4.5.1. Peripheral Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Urology Guidewires
  • 4.6.1. Urology Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.7. Neurovascular Guidewires
  • 4.7.1. Neurovascular Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
  • 5.2.1. Innovators
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. U.S. key company market share analysis, 2024
  • 5.3.4. Boston Scientific Corporation
    • 5.3.4.1. Company overview
    • 5.3.4.2. Financial performance
    • 5.3.4.3. Product benchmarking
    • 5.3.4.4. Strategic initiatives
  • 5.3.5. Medtronic
    • 5.3.5.1. Company overview
    • 5.3.5.2. Financial performance
    • 5.3.5.3. Product benchmarking
    • 5.3.5.4. Strategic initiatives
  • 5.3.6. Cook
    • 5.3.6.1. Company overview
    • 5.3.6.2. Financial performance
    • 5.3.6.3. Product benchmarking
    • 5.3.6.4. Strategic initiatives
  • 5.3.7. Terumo Medical Corporation
    • 5.3.7.1. Company overview
    • 5.3.7.2. Financial performance
    • 5.3.7.3. Product benchmarking
    • 5.3.7.4. Strategic initiatives
  • 5.3.8. Abbott
    • 5.3.8.1. Company overview
    • 5.3.8.2. Financial performance
    • 5.3.8.3. Product benchmarking
    • 5.3.8.4. Strategic initiatives
  • 5.3.9. Stryker
    • 5.3.9.1. Company overview
    • 5.3.9.2. Financial performance
    • 5.3.9.3. Product benchmarking
    • 5.3.9.4. Strategic initiatives
  • 5.3.10. Teleflex Incorporated
    • 5.3.10.1. Company overview
    • 5.3.10.2. Financial performance
    • 5.3.10.3. Product benchmarking
    • 5.3.10.4. Strategic initiatives
  • 5.3.11. BD
    • 5.3.11.1. Company overview
    • 5.3.11.2. Financial performance
    • 5.3.11.3. Product benchmarking
    • 5.3.11.4. Strategic initiatives
  • 5.3.12. ASAHI INTECC USA, INC.
    • 5.3.12.1. Company overview
    • 5.3.12.2. Financial performance
    • 5.3.12.3. Product benchmarking
    • 5.3.12.4. Strategic initiatives
  • 5.3.13. Olympus America
    • 5.3.13.1. Company overview
    • 5.3.13.2. Financial performance
    • 5.3.13.3. Product benchmarking
    • 5.3.13.4. Strategic initiatives
  • 5.3.14. Dornier MedTech.
    • 5.3.14.1. Company overview
    • 5.3.14.2. Financial performance
    • 5.3.14.3. Product benchmarking
    • 5.3.14.4. Strategic initiatives
  • 5.3.15. Koninklijke Philips N.V.
    • 5.3.15.1. Company overview
    • 5.3.15.2. Financial performance
    • 5.3.15.3. Product benchmarking
    • 5.3.15.4. Strategic initiatives
• 5.4. Heat Map Analysis/ Company Market Position Analysis
• 5.5. Estimated Company Market Share Analysis, 2024
• 5.6. List of Other Key Market Players